NCT00398112
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +16 more
- Locations
-
- North Central Cancer Treatment Group Rochester, Minnesota, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,057 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
NCT00802737
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- GSK Investigational Site Örebro, Sweden
- GSK Investigational Site Stockholm, Sweden
NCT00600964
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of CA- San Diego La Jolla, California, United States
- Lombardi Cancer Center Washington D.C., District of Columbia, United States
- Milton S Hershey Medical Center Penn State Cancer Institute Hershey, Pennsylvania, United States
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT00303953
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT01130194
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Saint Louis University Cancer Center St Louis, Missouri, United States
NCT00431769
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Graz, Austria
- Oberpullendorf, Austria
- Vienna, Austria
- Antwerp, Belgium
NCT01131221
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
Not specified
NCT00076349
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Alaska Cancer Research and Education Center Anchorage, Alaska, United States
- Bay Area Cancer Research Group Concord, California, United States
- Wilshire Oncology Medical Group La Verne, California, United States
- USC/Kenneth Norris Jr. Cancer Hospital and Research Institute Los Angeles, California, United States
Completed
Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.
NCT00392314
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- RAMBAM health care campus Haifa, Israel
NCT00139841
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- Arizona Cancer Center Tucson, Arizona, United States
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- Tower Hematology and Oncology Medical Group Beverly Hills, California, United States